Editorial
Circulating tumour DNA and resistance mechanisms during EGFR inhibitor therapy in lung cancer
Abstract
The lung cancer patient had tolerated well the first few cycles of her treatment. Her breathlessness improved but the pain in the ribcage was still difficult to control. The computer tomography scan showed enlargement of the bone lesions and regression of the primary tumour. Would you continue this treatment or would you change it?
